Teladoc Health Reports Second-Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
Teladoc (TDOC) PT Lowered to $40 at JPMorgan, 'We expect the stock to be a show-me story in the near term'
July 28, 2022 12:26 PM EDTJPMorgan analyst Lisa Gill lowered the price target on Teladoc (NYSE: TDOC) to $40.00 (from $53.00) while maintaining a Neutral rating.
The analyst comments "We highlight a significant market opportunity for telehealth services, which helps to solve two key issues affecting the... More
Teladoc (TDOC) Misses Q2 EPS
July 27, 2022 4:07 PM EDTTeladoc (NYSE: TDOC) reported Q2 EPS of ($19.22), which may not compare to the analyst estimate of ($0.64). Revenue for the quarter came in at $592.4 million versus the consensus estimate of $587.71 million.
GUIDANCE:
Teladoc sees Q3 2022 EPS of ($0.85)-($0.60), versus the consensus... More
